CIK: 0001822947 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 15, 2024
Total Value ($000): $179,888 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | BLUEPRINT MEDICINES CORP | 160,950 | $15,268 | 8.5% | $94.86 | — | COM | 09627Y109 |
| SLNO | SOLENO THERAPEUTICS INC | 336,486 | $14,402 | 8.0% | $29.77 | +51.9% | COM | 834203309 |
| CGON | CG ONCOLOGY INC | 320,378 | $14,065 | 7.8% | $40.84 | 0.0% | COM | 156944100 |
| XENE | XENON PHARMACEUTICALS INC | 309,369 | $13,318 | 7.4% | $38.92 | +18.2% | COM | 98420N105 |
| — | VERONA PHARMA PLC | 736,738 | $11,854 | 6.6% | $16.09 | — | SPONSORED ADS | 925050106 |
| — | MERUS N V | 255,928 | $11,524 | 6.4% | $20.59 | — | COM | N5749R100 |
| PRAX | PRAXIS PRECISION MEDICINES I | 159,486 | $9,732 | 5.4% | $33.00 | +35.9% | COM | 74006W207 |
| — | MIND MEDICINE MINDMED INC | 1,001,452 | $9,414 | 5.2% | $9.40 | — | COM NEW | 60255C885 |
| — | AVADEL PHARMACEUTICALS PLC | 547,036 | $9,239 | 5.1% | $15.13 | — | SPONSORED ADR | 05337M104 |
| GERN | GERON CORP | 2,760,497 | $9,110 | 5.1% | $2.61 | -14.6% | COM | 374163103 |
| JSPR | JASPER THERAPEUTICS INC | 289,943 | $8,513 | 4.7% | $17.76 | 0.0% | COM NEW | 471871202 |
| KURA | KURA ONCOLOGY INC | 365,044 | $7,786 | 4.3% | $19.44 | 0.0% | COM | 50127T109 |
| INSM | INSMED INC | 250,000 | $6,783 | 3.8% | $27.99 | 0.0% | COM PAR $.01 | 457669307 |
| DNTH | DIANTHUS THERAPEUTICS INC | 216,968 | $6,509 | 3.6% | $21.73 | 0.0% | COM | 252828108 |
| OLMA | OLEMA PHARMACEUTICALS INC | 559,035 | $6,328 | 3.5% | $13.44 | -4.0% | COM | 68062P106 |
| — | LYRA THERAPEUTICS INC | 1,003,741 | $6,243 | 3.5% | $6.22 | — | COM | 55234L105 |
| — | LONGBOARD PHARMACEUTICALS IN | 270,559 | $5,844 | 3.2% | $21.60 | — | COM | 54300N103 |
| — | RAPT THERAPEUTICS INC | 420,000 | $3,772 | 2.1% | $8.98 | — | COM | 75382E109 |
| — | MERSANA THERAPEUTICS INC | 801,437 | $3,590 | 2.0% | $4.48 | — | COM | 59045L106 |
| — | MARINUS PHARMACEUTICALS INC | 394,773 | $3,569 | 2.0% | $9.04 | — | COM NEW | 56854Q200 |
| — | PROMIS NEUROSCIENCES INC | 1,059,582 | $2,024 | 1.1% | $1.56 | — | COM NEW | 74346M406 |
| CNTX | CONTEXT THERAPEUTICS INC | 725,951 | $1,002 | 0.6% | $0.88 | +28.0% | COM | 21077P108 |